Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Seripa

Showing results (31-40 of 225) with videos related to

Pageof 23
Sort By:
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex PhenotypeFrancesco Panza, Davide Seripa, Vincenzo Solfrizzi, et al.
Neurobiology of Aging|August 17, 2014
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementiaEnrico Premi, Silvana Archetti, Andrea Pilotto, et al.
The American Journal of Gastroenterology|August 30, 2008
The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter studyAlberto Pilotto, Marilisa Franceschi, Dino Vitale, et al.
Archives of Neurology|July 15, 2009
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in womenAntonio Daniele, Maria G Matera, Davide Seripa, et al.
Rejuvenation Research|March 27, 2015
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical ConditionFrancesco Panza, Vincenzo Solfrizzi, Maria Rosaria Barulli, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanismsVincenza Frisardi, Francesco Panza, Davide Seripa, et al.
Nature Reviews. Neurology|March 24, 2020
Development of disease-modifying drugs for frontotemporal dementia spectrum disordersFrancesco Panza, Madia Lozupone, Davide Seripa, et al.
Expert Review of Neurotherapeutics|May 5, 2011
Diet and Alzheimer's disease risk factors or prevention: the current evidenceVincenzo Solfrizzi, Francesco Panza, Vincenza Frisardi, et al.
Expert Review of Neurotherapeutics|August 2, 2014
Efficacy and safety studies of gantenerumab in patients with Alzheimer's diseaseFrancesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo, et al.
Current Drug Targets|November 5, 2016
Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic ReviewGrazia D'Onofrio, Daniele Sancarlo, Qingwei Ruan, et al.
Pageof 23

Showing results (31-40 of 225) with videos related to

Sort By:
Pageof 23
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex PhenotypeFrancesco Panza, Davide Seripa, Vincenzo Solfrizzi, et al.
Neurobiology of Aging|August 17, 2014
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementiaEnrico Premi, Silvana Archetti, Andrea Pilotto, et al.
The American Journal of Gastroenterology|August 30, 2008
The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter studyAlberto Pilotto, Marilisa Franceschi, Dino Vitale, et al.
Archives of Neurology|July 15, 2009
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in womenAntonio Daniele, Maria G Matera, Davide Seripa, et al.
Rejuvenation Research|March 27, 2015
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical ConditionFrancesco Panza, Vincenzo Solfrizzi, Maria Rosaria Barulli, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanismsVincenza Frisardi, Francesco Panza, Davide Seripa, et al.
Nature Reviews. Neurology|March 24, 2020
Development of disease-modifying drugs for frontotemporal dementia spectrum disordersFrancesco Panza, Madia Lozupone, Davide Seripa, et al.
Expert Review of Neurotherapeutics|May 5, 2011
Diet and Alzheimer's disease risk factors or prevention: the current evidenceVincenzo Solfrizzi, Francesco Panza, Vincenza Frisardi, et al.
Expert Review of Neurotherapeutics|August 2, 2014
Efficacy and safety studies of gantenerumab in patients with Alzheimer's diseaseFrancesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo, et al.
Current Drug Targets|November 5, 2016
Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic ReviewGrazia D'Onofrio, Daniele Sancarlo, Qingwei Ruan, et al.
Pageof 23